Finance

Beta
Lists
COAG:NASDAQ
Hemab Therapeutics Holdings Inc
$25.30
-0.43%
(-0.11) 1D
$25.30
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COAG...
Open
$25.62
High
$26.40
Low
$24.50
Mkt. cap
1.18B
Avg. vol.
303.05K
Volume
184.20K
52-wk high
$36.56
52-wk low
$23.00
No. of employees
72
Open
$25.62
High
$26.40
Low
$24.50
Mkt. cap
1.18B
Avg. vol.
303.05K
Volume
184.20K
52-wk high
$36.56
52-wk low
$23.00
No. of employees
72
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to COAG in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for COAG in the last 3 months.
Highest
Current $25.30
$50.00 (+97.63%)
Average
$41.75 (+65.02%)
Lowest
$36.00 (+42.29%)
News stories
From sources across the web
About Hemab Therapeutics Holdings Inc
CEO-
Employees72
Founded2020
Headquarters-
SectorBiotechnology
Websitehemab.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer